<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-81551" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Copper Toxicity</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Royer</surname>
            <given-names>Amor</given-names>
          </name>
          <aff>University of Mississippi Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sharman</surname>
            <given-names>Tariq</given-names>
          </name>
          <aff>Southern Ohio Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Amor Royer declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Tariq Sharman declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>27</day>
          <month>3</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-81551.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Copper metabolism plays an important role in physiologic homeostasis. Copper toxicity, however, induces several pathologic processes that are detrimental to human health. This discussion highlights the role of the interprofessional team in managing patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the importance of early recognition of copper toxicity in regards to improving patient outcomes.</p></list-item><list-item><p>Outline the potential risk factors for copper toxicity.</p></list-item><list-item><p>Review the first and second-line treatments available to patients with copper toxicity.</p></list-item><list-item><p>Explain the importance of improving patient education by an interprofessional team to enhance the prevention of copper toxicity.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=81551&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=81551">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-81551.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Copper is a trace element (minerals required in amounts 1 to 100 mg/day by adults) found in high concentrations in the brain, liver, and kidney. However, because of their size, bone and muscle contain more than half of the copper in the body.<xref ref-type="bibr" rid="article-81551.r1">[1]</xref> Copper is bound to ceruloplasmin in the liver, which transports the copper from the liver to the peripheral tissues. Approximately 50 percent of copper is excreted in the bile, while the remaining half is excreted through other gastrointestinal secretions.<xref ref-type="bibr" rid="article-81551.r2">[2]</xref> As such, the gastrointestinal tract is the major regulator of copper homeostasis.</p>
        <p>While copper is required as an important catalytic cofactor in redox chemistry for many proteins, when present in excess, free copper ions can cause damage to cellular components. A delicate balance between the uptake and efflux of copper ions determines the amount of cellular copper.<xref ref-type="bibr" rid="article-81551.r3">[3]</xref> Excess copper induces not only oxidative stress but also DNA damage and reduced cell proliferation.<xref ref-type="bibr" rid="article-81551.r4">[4]</xref> Ingestion of more than 1 g of copper sulfate results in symptoms of toxicity. Copper toxicosis can be classified as primary when it results from an inherited metabolic defect and secondary when it results from high intake or increased absorption or reduced excretion due to underlying pathologic processes.<xref ref-type="bibr" rid="article-81551.r5">[5]</xref>&#x000a0;Copperiedus (copper toxicity) can&#x000a0;be caused by&#x000a0;consuming acidic foods cooked in uncoated copper cookware or exposure to excess copper in drinking water or other environmental sources.</p>
      </sec>
      <sec id="article-81551.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Many instances of copper toxicity are often the result of accidental consumption or installation of contaminated water sources, copper salt-containing topical creams for burn treatments, acidic foods cooked in uncoated copper cookware, or in suicide attempts (the lethal dose of ingested copper is (10 to 20 g). Copper sulfate is an easily accessible chemical in many countries and is even sold over the counter. It is commonly used in farming as a pesticide in the leather industry and making home-made glue. The burning of copper sulfate in houses and shops (as a good luck charm and for some religious activities) is a common practice among Buddhists and Hindus. The bright blue color of the hydrated form of copper sulfate crystals is alluring to children and is a frequent reason for inadvertent poisoning.<xref ref-type="bibr" rid="article-81551.r6">[6]</xref> Wilson disease is an autosomal recessive disorder characterized by excessive copper accumulation and is caused by a variant in the gene encoding a copper-ATPase enzyme.<xref ref-type="bibr" rid="article-81551.r7">[7]</xref>&#x000a0;Copper in the blood exists in two forms: bound to ceruloplasmin (85% to 95%), and the rest "free," loosely bound to albumin&#x000a0;and other small molecules.</p>
      </sec>
      <sec id="article-81551.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The incidence of copper poisoning varies largely by region, but it is uncommon in Western countries; it is more common in South Asian countries where it is more prevalent in rural populations. Copper toxicity risks are higher for neonates and infants as they have an immature biliary excretion system and enhanced intestinal absorption.<xref ref-type="bibr" rid="article-81551.r1">[1]</xref> Copper overload is also a feature of Indian childhood cirrhosis, endemic Tyrolean infantile cirrhosis, and idiopathic copper toxicosis.<xref ref-type="bibr" rid="article-81551.r8">[8]</xref></p>
      </sec>
      <sec id="article-81551.s5" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Signs of overt acute copper toxicity depend somewhat on the mode of copper overload with ingestions presenting most commonly with gastrointestinal side effects such as abdominal pain, hematemesis, melena, jaundice, anorexia, severe thirst, diarrhea, and vomiting associated with erosive gastropathy.<xref ref-type="bibr" rid="article-81551.r6">[6]</xref> Evidence of characteristic blue-green material in emesis/stool is highly suggestive. Altered mentation, headache, coma, and tachycardia may also accompany GI side effects.<xref ref-type="bibr" rid="article-81551.r9">[9]</xref> Patients with an intravascular mode of copper toxicity (i.e., contaminated hemodialysis fluid infusion) can present with signs/symptoms of intravascular hemolysis, and individuals with glucose-6-phosphate deficiency are at higher risk for the hematologic adverse effects of copper. Neurological symptoms such as&#x000a0;depression, fatigue,&#x000a0;irritability, excitation, and difficulty focusing are reported too. In most severe forms, copper toxicity leads to rhabdomyolysis, cardiac and renal failure, methemoglobinemia, intravascular hemolysis, hepatic necrosis, encephalopathy, and ultimately death.<xref ref-type="bibr" rid="article-81551.r10">[10]</xref></p>
      </sec>
      <sec id="article-81551.s6" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Measurement of urine and blood copper levels in addition to serum ceruloplasmin levels remain the mainstay of copper toxicity initial evaluations if history and physical exam raise clinical suspicion.<xref ref-type="bibr" rid="article-81551.r11">[11]</xref> Fecal evaluation of copper levels may also be obtained in the evaluation of acute copper poisoning. Other laboratory evaluative tests include measures of kidney function, hemolysis, and liver damage (namely liver function tests, including ASL/ALT, which will likely be increased). During the hemolytic crisis, methemoglobinemia, other measures of RBC lysis, and decreased blood glutathione are often seen.<xref ref-type="bibr" rid="article-81551.r12">[12]</xref></p>
      </sec>
      <sec id="article-81551.s7" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The therapeutic management of copper toxicity focuses on 4 major principles: Reduction of absorption, close observation, supportive measures with the management of complications, and chelation therapy.<xref ref-type="bibr" rid="article-81551.r13">[13]</xref><xref ref-type="bibr" rid="article-81551.r10">[10]</xref> In the early stages, pharmacologic doses of zinc may be effective in delaying the onset of symptomatic disease because zinc competes with copper for absorption in the gastrointestinal tract. Zinc also induces metallothionein (an endogenous chelator of metals) in enterocytes, which has a greater affinity for copper than for zinc, causing it to bind luminal copper and thereby preventing its entry into the circulation.<xref ref-type="bibr" rid="article-81551.r3">[3]</xref>&#x000a0;</p>
        <p>D-Penicillamine is the primary chelator used in copper toxicity, although EDTA (Ethylenediaminetetraacetic acid)&#x000a0;and DMPS (dimercaptopropanesulfonic acid) may also be used for heavy metal toxicity with copper.<xref ref-type="bibr" rid="article-81551.r14">[14]</xref> However, approximately 30 percent of patients do not tolerate long-term therapy because of side effects, and it may not be the treatment of choice in patients with neurologic symptoms. Trientine has traditionally been used as a second-line agent for those intolerant of D-penicillamine to enhance cupriuresis. A liver transplant may be&#x000a0;necessary in severe cases, although liver transplantation is not recommended for patients with neurological and psychiatric symptoms.<xref ref-type="bibr" rid="article-81551.r13">[13]</xref> Ammonium tetrathiomolybdate is another potential therapy but has not yet been approved in the US. In severe cases, plasmapheresis, exchange transfusion, molecular adsorbent recirculating system (MARS), or dialysis may be required as bridges to transplant if a transplant is deemed necessary.</p>
      </sec>
      <sec id="article-81551.s8" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Other heavy metal toxicities may present similarly and also must be ruled out. In children, chronic copper toxicity may be phenotypically very similar to Pink disease (infantile acrodynia).<xref ref-type="bibr" rid="article-81551.r15">[15]</xref></p>
      </sec>
      <sec id="article-81551.s9" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Prognosis is poor if not treated promptly with chelation and supportive measures as 14% to 36% of the patients pass away within a few hours of a toxic ingestion.<xref ref-type="bibr" rid="article-81551.r10">[10]</xref> However, with prompt and effective management, the neurologic, psychiatric, and hepatic abnormalities gradually improve with treatment, and liver biochemical test results usually return to normal.</p>
      </sec>
      <sec id="article-81551.s10" sec-type="Complications">
        <title>Complications</title>
        <p>Ingestion may lead to stricture formation throughout the gastrointestinal tract. Acute liver failure can occur due to direct copper toxicity-induced tissue necrosis.<xref ref-type="bibr" rid="article-81551.r6">[6]</xref> Whether patients are at increased risk of hepatocellular carcinoma (HCC) is not clear, but to date, no study has yet shown an increase in HCC attributable to copper ingestion.</p>
      </sec>
      <sec id="article-81551.s11" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Stopping the over-the-counter sale of copper sulfate and the restriction of purchase, distribution, and sale to authorized agents is important in decreasing the incidence of copper toxicity. Alternatively, over-the-counter availability of copper sulfate can be limited to large crystals as cases of poisoning are usually due to inadvertent/intentional dissolving of the fine powder-like pulverized form of the compound.<xref ref-type="bibr" rid="article-81551.r6">[6]</xref>&#x000a0;Copper is an additive to infant formula and can be found in breast milk. An increase in copper breast milk concentrations has not been observed following the insertion of the copper intrauterine device. As such, the use of a copper IUD is not expected to impact lactation and is considered compatible with breastfeeding.<xref ref-type="bibr" rid="article-81551.r16">[16]</xref></p>
      </sec>
      <sec id="article-81551.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Treatment is most effective when it is applied early in the course of the encounter. This necessitates&#x000a0;that all interprofessional healthcare team members, including clinicians, mid-level practitioners, nurses, and pharmacists, be familiar with identifying the signs and symptoms of copper toxicity and take action to initiate prompt treatment and management of the patient's condition, resulting in better outcomes. [Level 5]</p>
        <p>Patients at higher risk (i.e., those with Wilson disease) should&#x000a0;receive education on modes of excessive copper exposure, avoidance of excessive copper intake, and signs and symptoms that may be concerning for worsening copper overload. Screening of siblings and children of patients with Wilson disease may elucidate those at higher risk.</p>
      </sec>
      <sec id="article-81551.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=81551&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=81551">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/copper-toxicity/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=81551">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/81551/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=81551">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-81551.s14">
        <title>References</title>
        <ref id="article-81551.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Collins</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Klevay</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Copper.</article-title>
            <source>Adv Nutr</source>
            <year>2011</year>
            <month>Nov</month>
            <volume>2</volume>
            <issue>6</issue>
            <fpage>520</fpage>
            <page-range>520-2</page-range>
            <pub-id pub-id-type="pmid">22332094</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81551.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mason</surname>
                <given-names>KE</given-names>
              </name>
            </person-group>
            <article-title>A conspectus of research on copper metabolism and requirements of man.</article-title>
            <source>J Nutr</source>
            <year>1979</year>
            <month>Nov</month>
            <volume>109</volume>
            <issue>11</issue>
            <fpage>1979</fpage>
            <page-range>1979-2066</page-range>
            <pub-id pub-id-type="pmid">387922</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81551.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tapiero</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Townsend</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Tew</surname>
                <given-names>KD</given-names>
              </name>
            </person-group>
            <article-title>Trace elements in human physiology and pathology. Copper.</article-title>
            <source>Biomed Pharmacother</source>
            <year>2003</year>
            <month>Nov</month>
            <volume>57</volume>
            <issue>9</issue>
            <fpage>386</fpage>
            <page-range>386-98</page-range>
            <pub-id pub-id-type="pmid">14652164</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81551.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Miyagawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Honma</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Harada</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Copper induces hepatocyte injury due to the endoplasmic reticulum stress in cultured cells and patients with Wilson disease.</article-title>
            <source>Exp Cell Res</source>
            <year>2016</year>
            <month>Sep</month>
            <day>10</day>
            <volume>347</volume>
            <issue>1</issue>
            <fpage>192</fpage>
            <page-range>192-200</page-range>
            <pub-id pub-id-type="pmid">27502587</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81551.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fuentealba</surname>
                <given-names>IC</given-names>
              </name>
              <name>
                <surname>Aburto</surname>
                <given-names>EM</given-names>
              </name>
            </person-group>
            <article-title>Animal models of copper-associated liver disease.</article-title>
            <source>Comp Hepatol</source>
            <year>2003</year>
            <month>Apr</month>
            <day>03</day>
            <volume>2</volume>
            <issue>1</issue>
            <fpage>5</fpage>
            <pub-id pub-id-type="pmid">12769823</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81551.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gamakaranage</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Rodrigo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Weerasinghe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gnanathasan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Puvanaraj</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Fernando</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Complications and management of acute copper sulphate poisoning; a case discussion.</article-title>
            <source>J Occup Med Toxicol</source>
            <year>2011</year>
            <month>Dec</month>
            <day>19</day>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>34</fpage>
            <pub-id pub-id-type="pmid">22182712</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81551.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sturniolo</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Mestriner</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Irato</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Albergoni</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Longo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>D'Inc&#x000e0;</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.</article-title>
            <source>Am J Gastroenterol</source>
            <year>1999</year>
            <month>Feb</month>
            <volume>94</volume>
            <issue>2</issue>
            <fpage>334</fpage>
            <page-range>334-8</page-range>
            <pub-id pub-id-type="pmid">10022625</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81551.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Coronado</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Bonneville</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Nazer</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Cox</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>COMMD1 (MURR1) as a candidate in patients with copper storage disease of undefined etiology.</article-title>
            <source>Clin Genet</source>
            <year>2005</year>
            <month>Dec</month>
            <volume>68</volume>
            <issue>6</issue>
            <fpage>548</fpage>
            <page-range>548-51</page-range>
            <pub-id pub-id-type="pmid">16283886</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81551.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hordyjewska</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Popio&#x00142;ek</surname>
                <given-names>&#x00141;</given-names>
              </name>
              <name>
                <surname>Kocot</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>The many "faces" of copper in medicine and treatment.</article-title>
            <source>Biometals</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>27</volume>
            <issue>4</issue>
            <fpage>611</fpage>
            <page-range>611-21</page-range>
            <pub-id pub-id-type="pmid">24748564</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81551.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harris</surname>
                <given-names>ED</given-names>
              </name>
            </person-group>
            <article-title>Cellular copper transport and metabolism.</article-title>
            <source>Annu Rev Nutr</source>
            <year>2000</year>
            <volume>20</volume>
            <fpage>291</fpage>
            <page-range>291-310</page-range>
            <pub-id pub-id-type="pmid">10940336</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81551.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buchwald</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Serum copper elevation from estrogen effect, masquerading as fungicide toxicity.</article-title>
            <source>J Med Toxicol</source>
            <year>2008</year>
            <month>Mar</month>
            <volume>4</volume>
            <issue>1</issue>
            <fpage>30</fpage>
            <page-range>30-2</page-range>
            <pub-id pub-id-type="pmid">18338309</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81551.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Malkarnekar</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Anjanappa</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Naveen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kiran</surname>
                <given-names>BG</given-names>
              </name>
            </person-group>
            <article-title>Acute methemoglobinemia with hemolytic anemia following bio-organic plant nutrient compound exposure: Two case reports.</article-title>
            <source>Indian J Crit Care Med</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>115</fpage>
            <page-range>115-7</page-range>
            <pub-id pub-id-type="pmid">24678158</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81551.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Murray</surname>
                <given-names>KF</given-names>
              </name>
              <name>
                <surname>Carithers</surname>
                <given-names>RL</given-names>
              </name>
              <collab>AASLD</collab>
            </person-group>
            <article-title>AASLD practice guidelines: Evaluation of the patient for liver transplantation.</article-title>
            <source>Hepatology</source>
            <year>2005</year>
            <month>Jun</month>
            <volume>41</volume>
            <issue>6</issue>
            <fpage>1407</fpage>
            <page-range>1407-32</page-range>
            <pub-id pub-id-type="pmid">15880505</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81551.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sinkovic</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Strdin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Svensek</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Severe acute copper sulphate poisoning: a case report.</article-title>
            <source>Arh Hig Rada Toksikol</source>
            <year>2008</year>
            <month>Mar</month>
            <volume>59</volume>
            <issue>1</issue>
            <fpage>31</fpage>
            <page-range>31-5</page-range>
            <pub-id pub-id-type="pmid">18407869</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81551.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salmon</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Chronic copper poisoning presenting as pink disease.</article-title>
            <source>Arch Dis Child</source>
            <year>1971</year>
            <month>Feb</month>
            <volume>46</volume>
            <issue>245</issue>
            <fpage>108</fpage>
            <page-range>108-10</page-range>
            <pub-id pub-id-type="pmid">5555482</pub-id>
          </element-citation>
        </ref>
        <ref id="article-81551.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berens</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Labbok</surname>
                <given-names>M</given-names>
              </name>
              <collab>Academy of Breastfeeding Medicine</collab>
            </person-group>
            <article-title>ABM Clinical Protocol #13: Contraception During Breastfeeding, Revised 2015.</article-title>
            <source>Breastfeed Med</source>
            <year>2015</year>
            <season>Jan-Feb</season>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-12</page-range>
            <pub-id pub-id-type="pmid">25551519</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
